{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-24-087267","form_type":"8-K","ticker":"CERO","cik":"0001870404","company_name":"CERO THERAPEUTICS HOLDINGS, INC.","filed_at":"2024-10-11T23:59:59+00:00","discovered_at":"2026-05-14T18:03:10.196907+00:00","generated_at":"2026-05-30T15:41:59.025453+00:00","sec_items":["2.02","5.02","7.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"medium","headline":"CERo Therapeutics reports $3.3M preliminary cash; appoints Shami Patel to board","bullets":["Preliminary unaudited cash and cash equivalents as of Sept 30, 2024 were approximately $3.3 million.","Board appointed Shami Patel as Class III director effective Oct 11, 2024, filling vacancy from Dr. Corey's resignation.","Cash estimate is preliminary and subject to change upon completion of quarter-end close; no audit performed.","Patel is a Managing Director at Launchpad Capital with extensive SPAC and financial services experience."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-24-087267","json":"https://secwatch.observer/filing/0001213900-24-087267.json","markdown":"https://secwatch.observer/filing/0001213900-24-087267.md","text":"https://secwatch.observer/filing/0001213900-24-087267.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1870404/000121390024087267/0001213900-24-087267-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1870404/000121390024087267/ea0217430-8k_cero.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T15:41:59.025453+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"85daadad7a","claim":"Shami Patel was appointed as Class III Director at CERO THERAPEUTICS HOLDINGS, INC..","evidence_excerpt":"On October 9, 2024, the Board of Directors (the “ Board ”) of the Company appointed Shami Patel to the Board as a Class III director, effective October 11, 2024, to fill the vacancy created by Dr. Corey’s resignation","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1870404/000121390024087267/0001213900-24-087267-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Class III Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}